Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
Instead of carcinogenicity
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
Instead of genotoxicity
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
DRG histopathology
Not stated in public reviews
Not reported in the public reviews. Reviewers summarise selectively, so this usually means it wasn't discussed publicly, not that it wasn't studied.
Reproductive & developmental
Durlobactam rat fertility/EFD study: no toxicologically significant effects up to 3x clinical AUC
“At doses up to 3 times the maximum recommended dose based on AUC comparisons, there were no toxicologically significant drug-related effects of durlobactam in pups born to rats dosed for 2 weeks prior to pairing, during pairing, and up to gestation Day 17.”
No safety signals in safety pharmacology studies; no potent secondary pharmacology activity
“There were no safety signals observed in safety pharmacology studies. Secondary pharmacology data did not reveal any potent activity among 192 pharmacology receptors/enzymes evaluated.”
“The study is not considered to be a valid assessment of the mutagenicity of durlobactam, since toxicity precluded testing of the strains at doses above 5 μg/plate.”
Not genotoxic overall: Ames negative; in vitro chromosome aberration positive without (not with) metabolic activation; rat micronucleus and comet negative